Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

Dr. Sulaiman Al Habib Medical Services stock: At SAR 218.30, 31.59 times earnings

Published on 10/20/2026 at 16:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

2025 revenue reached SAR 13,706.90 million. Al Habib stock costs SAR 218.30 on October 20, 2026, down 0.41 percent on Tadawul.

Valuation and operating scale

Dr. Sulaiman Al Habib Medical Services traded at 31.59 times earnings on October 20, 2026.
Revenue reached SAR 13,706.90 million in fiscal year 2025.
Dr. Sulaiman Al Habib Medical Services stock last traded at SAR 218.30 on October 20, 2026, down 0.41 percent versus SAR 219.20.
The stock stood 22.04 percent below its SAR 280.00 52-week high.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

At SAR 218.30, Dr. Sulaiman Al Habib Medical Services traded at 31.59 times earnings on October 20, 2026, while Mouwasat Medical Services traded at 13.62 times earnings. Global Banking & Finance Review identifies the company as 4013.SR on Tadawul under ISIN SA1510P1UMH1, confirming the Saudi listing and healthcare classification. The latest quoted change was down 0.41 percent from SAR 219.20 at 3:19 p.m. AST on October 20, 2026.

Revenue reached SAR 13,706.90 million

Annual revenue rose from SAR 11,200.43 million in fiscal year 2024 to SAR 13,706.90 million in fiscal year 2025, a 22.38 percent increase. The figures come from Reuters, which also lists fiscal-year 2025 net income of SAR 2,401.47 million, compared with SAR 2,315.29 million in fiscal year 2024.

Price position remains below the high

The stock's 52-week range was SAR 210.10 to SAR 280.00 on October 20, 2026. At SAR 218.30, it stood 22.04 percent below the upper end and 3.90 percent above the lower end. Trading volume reached 156,174 shares, while market capitalization was SAR 76.4 billion.

Valuation differs across healthcare peers

Dr. Sulaiman Al Habib Medical Services carried a 31.59 times earnings multiple and SAR 76.4 billion market capitalization. Its valuation was higher than the multiples of the two Saudi healthcare peers listed below, although daily price movements were weaker across the group.

Comparison with peers

Dr. Sulaiman Al Habib Medical Services (Tadawul, SAR): down 0.41 percent, P/E 31.59, market capitalization SAR 76.4 billion.

Mouwasat Medical Services (Tadawul, SAR): down 1.02 percent, P/E 13.62, market capitalization SAR 11.6 billion.

Dallah Healthcare Company (Tadawul, SAR): down 3.48 percent, P/E 15.53, market capitalization SAR 8.2 billion.

Stock remains close to its yearly low

The distance to the 52-week low was 3.90 percent on October 20, 2026, leaving the stock materially nearer that level than its SAR 280.00 high. The valuation comparison and the 2025 revenue increase put the current quotation alongside both earnings scale and relative pricing.